WO2002024685A8 - Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires - Google Patents

Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires

Info

Publication number
WO2002024685A8
WO2002024685A8 PCT/FR2001/002950 FR0102950W WO0224685A8 WO 2002024685 A8 WO2002024685 A8 WO 2002024685A8 FR 0102950 W FR0102950 W FR 0102950W WO 0224685 A8 WO0224685 A8 WO 0224685A8
Authority
WO
WIPO (PCT)
Prior art keywords
antifungal
indole derivatives
antiparasitic agents
antiparasitic
agents
Prior art date
Application number
PCT/FR2001/002950
Other languages
English (en)
Other versions
WO2002024685A1 (fr
Inventor
Borgne Marc Le
Young Min Na
Fabrice Pagniez
Baut Guillaume Le
Pape Patrice Le
Hiam Abdala
Original Assignee
Yang Ji Chemical Company Ltd
Borgne Marc Le
Young Min Na
Fabrice Pagniez
Baut Guillaume Le
Pape Patrice Le
Hiam Abdala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yang Ji Chemical Company Ltd, Borgne Marc Le, Young Min Na, Fabrice Pagniez, Baut Guillaume Le, Pape Patrice Le, Hiam Abdala filed Critical Yang Ji Chemical Company Ltd
Priority to US10/381,293 priority Critical patent/US20040067998A1/en
Priority to EP01972184A priority patent/EP1322638A1/fr
Priority to JP2002529095A priority patent/JP2004509886A/ja
Priority to AU2001291973A priority patent/AU2001291973A1/en
Priority to CA002423151A priority patent/CA2423151A1/fr
Publication of WO2002024685A1 publication Critical patent/WO2002024685A1/fr
Publication of WO2002024685A8 publication Critical patent/WO2002024685A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne de nouveaux dérivés indoliques, leur procédé de préparation et leur activité pharmacologique en tant que composés antimycotiques et/ou antiparasitaires.
PCT/FR2001/002950 2000-09-21 2001-09-21 Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires WO2002024685A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/381,293 US20040067998A1 (en) 2000-09-21 2001-09-21 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition
EP01972184A EP1322638A1 (fr) 2000-09-21 2001-09-21 Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires
JP2002529095A JP2004509886A (ja) 2000-09-21 2001-09-21 抗真菌及び／又は抗寄生虫用薬学的組成物、及びその組成物の活性成分としての新規のインドール誘導体
AU2001291973A AU2001291973A1 (en) 2000-09-21 2001-09-21 Indole derivatives and their use as antifungal and/or antiparasitic agents
CA002423151A CA2423151A1 (fr) 2000-09-21 2001-09-21 Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012050 2000-09-21
FR0012050A FR2814073B1 (fr) 2000-09-21 2000-09-21 Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition

Publications (2)

Publication Number Publication Date
WO2002024685A1 WO2002024685A1 (fr) 2002-03-28
WO2002024685A8 true WO2002024685A8 (fr) 2002-09-26

Family

ID=8854543

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/002950 WO2002024685A1 (fr) 2000-09-21 2001-09-21 Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires

Country Status (9)

Country Link
US (1) US20040067998A1 (fr)
EP (1) EP1322638A1 (fr)
JP (1) JP2004509886A (fr)
KR (1) KR20030046472A (fr)
CN (1) CN1473160A (fr)
AU (1) AU2001291973A1 (fr)
CA (1) CA2423151A1 (fr)
FR (1) FR2814073B1 (fr)
WO (1) WO2002024685A1 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877975B2 (en) 2006-01-06 2014-11-04 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
US8940752B2 (en) 2009-06-29 2015-01-27 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9096600B2 (en) 2010-12-20 2015-08-04 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
US9193721B2 (en) 2010-04-14 2015-11-24 Incyte Holdings Corporation Fused derivatives as PI3Kδ inhibitors
US9199982B2 (en) 2011-09-02 2015-12-01 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9309251B2 (en) 2012-04-02 2016-04-12 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US9403847B2 (en) 2009-12-18 2016-08-02 Incyte Holdings Corporation Substituted heteroaryl fused derivatives as P13K inhibitors
US12024522B2 (en) 2021-07-01 2024-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108671A1 (fr) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Indoles substitues dotes d'une affinite pour le recepteur de la serotonine, leur procede de fabrication et compositions pharmaceutiques les contenant
EP1756054B1 (fr) 2004-06-01 2010-03-31 F.Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles utiles comme inhibiteurs de la reabsorption de la monoamine
EP1871766A4 (fr) * 2005-03-30 2010-07-21 Dae Woong Pharma Derives de triazole antifongiques
WO2007062996A1 (fr) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles et indoles a substitution azo
ATE442368T1 (de) 2005-11-30 2009-09-15 Hoffmann La Roche 3-amino-2-arylpropylazaindole und anwendungen davon
BRPI0619247A2 (pt) 2005-11-30 2011-09-20 Hoffmann La Roche métodos para a sìntese de 3-amino-1-aril-propila indóis
WO2009042485A1 (fr) * 2007-09-24 2009-04-02 Allergan, Inc. Composés de type indole porteur de groupes hétéroaryles ayant une activité biologique de récepteur de la sphingosine-1-phosphate (s1p)
WO2011163195A1 (fr) 2010-06-21 2011-12-29 Incyte Corporation Dérivés condensés de pyrrole en tant qu'inhibiteurs de pi3k
WO2015191677A1 (fr) 2014-06-11 2015-12-17 Incyte Corporation Dérivés d'hétéroarylaminoalkylphényle bicycliques à titre d'inhibiteurs de pi3k
WO2016040764A1 (fr) * 2014-09-12 2016-03-17 Spero Therapeutics, Inc. N-benzimidazoles hétéroaryles bicycliques liés à du carbonyle et analogues utilisés en tant qu'inhibiteurs de tolérance aux antibiotiques
NZ734993A (en) 2015-02-27 2024-03-22 Incyte Holdings Corp Salts of pi3k inhibitor and processes for their preparation
WO2016144706A2 (fr) * 2015-03-11 2016-09-15 Pharmakea, Inc. Composés inhibiteurs de l'autotaxine et leurs utilisations
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
ES2708900A1 (es) * 2017-10-10 2019-04-11 Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa Nuevos derivados de gramina con efecto protector de la actividad fosfatasa, y su aplicacion en el tratamiento de enfermedades humanas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140858A (en) * 1977-12-19 1979-02-20 Warner-Lambert Company 3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
GR75101B (fr) * 1980-10-23 1984-07-13 Pfizer
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
TW297813B (fr) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877975B2 (en) 2006-01-06 2014-11-04 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
US8940752B2 (en) 2009-06-29 2015-01-27 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9434746B2 (en) 2009-06-29 2016-09-06 Incyte Corporation Pyrimidinones as PI3K inhibitors
US9403847B2 (en) 2009-12-18 2016-08-02 Incyte Holdings Corporation Substituted heteroaryl fused derivatives as P13K inhibitors
US9193721B2 (en) 2010-04-14 2015-11-24 Incyte Holdings Corporation Fused derivatives as PI3Kδ inhibitors
US9096600B2 (en) 2010-12-20 2015-08-04 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9527848B2 (en) 2010-12-20 2016-12-27 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
US9199982B2 (en) 2011-09-02 2015-12-01 Incyte Holdings Corporation Heterocyclylamines as PI3K inhibitors
US9309251B2 (en) 2012-04-02 2016-04-12 Incyte Holdings Corporation Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
US12024522B2 (en) 2021-07-01 2024-07-02 Incyte Corporation Salts and processes of preparing a PI3K inhibitor

Also Published As

Publication number Publication date
EP1322638A1 (fr) 2003-07-02
WO2002024685A1 (fr) 2002-03-28
CN1473160A (zh) 2004-02-04
FR2814073B1 (fr) 2005-06-24
FR2814073A1 (fr) 2002-03-22
CA2423151A1 (fr) 2002-03-28
KR20030046472A (ko) 2003-06-12
JP2004509886A (ja) 2004-04-02
AU2001291973A1 (en) 2002-04-02
US20040067998A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
WO2002024685A8 (fr) Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
IL157704A0 (en) 4,5-dihydro-1h-pyrazole derivatives having potent cbi-antagonistic activity
ZA200107983B (en) New compounds, their preparation and use.
HUP0105098A3 (en) Fungicidal n2-phenylamidine derivatives, intermediates and use thereof
ZA200309521B (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives.
MXPA03000939A (es) Derivados de imidazol.
IL150550A0 (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
MXPA03002452A (es) Derivados de resorcinol.
HK1069171A1 (en) Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents.
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
HUP0201492A2 (en) Herbicidal 3-hydroxi-4-aril-5-oxo-pyrazoline derivatives, intermediates preparation thereof
AU2001262105A1 (en) Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides
ZA200110021B (en) Substituted imidazothiazoles as antidepressant agents.
ZA200207341B (en) Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7a]indole compounds.
HK1052925A1 (en) Substituted 1-aminobutan-3-ol derivatives.
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
GB0130553D0 (en) 1,4-Dihydro-1,4-diphenylpyridine derivitives
ZA200208346B (en) Polyamide nucleic acid derivatives, agents and methods for producing the same.
PL370715A1 (en) [1.2]-oxazin-3,5-diones
ZA200205301B (en) New imidazole derivatives.
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
HUP0201035A3 (en) Substituted bezimidazole, the production thereof and the use thereof as means against parasitic protozoa
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001972184

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020037004417

Country of ref document: KR

Ref document number: 2423151

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002529095

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 01818555X

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020037004417

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001972184

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10381293

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001972184

Country of ref document: EP